37.43 -0.16 (-0.43%)
Pre-Market: 7:17AM EDT
|Bid||37.47 x 2200|
|Ask||37.43 x 800|
|Day's Range||37.43 - 37.79|
|52 Week Range||30.67 - 55.77|
|Beta (3Y Monthly)||0.78|
|PE Ratio (TTM)||1.70|
|Forward Dividend & Yield||2.70 (6.88%)|
|1y Target Est||46.96|
Altria, Juul and British American Tobacco — the largest U.S. cigarette and e-cigarette manufacturers — are supporting raising the smoking age to 21. Regulators are pressuring them to fix what they're calling an epidemic of teen vaping.
Battered by headwinds from changing consumer habits and a heavy-handed FDA, BTI is down. If the fundamentals check out, this could be a value buy for investors.
Stocks with juicy yields can lead to great cash flows for investors. Which of these tobacco giants is the dividend winner?
German shares led gains in Europe on Wednesday as robust earnings from the country's Siemens and Wirecard overshadowed mounting worries over a U.S.-China trade deal. Chinese Vice Premier Liu He will travel to Washington on Thursday for two days of trade talks, in a bid to avoid a sharp increase in tariffs on Chinese goods that U.S. President Donald Trump had threatened to impose over the weekend. "The fact that Chinese Vice-Premier Liu He is still expected to arrive in Washington to keep the talks going is probably the reason why this has not turned into an absolute meltdown," Elwin de Groot, head of macro strategy at Rabobank, said.
Investors betting on marijuana stocks got some disappointing news out of Canada last week. Statistics Canada reported that Canadian marijuana retail sales declined by 7% in February compared to January.Source: Shutterstock On the surface, that decline may seem troubling, but it's not actually as bad as it seems. There is plenty of demand for Canadian marijuana. Unfortunately, there is not nearly enough supply to meet that demand. As a result, Canadian producers are in high demand, a dynamic that bodes well for marijuana stocks. Consolidation AheadThe drop in Canadian retail sales in February underscores just how critical the marijuana supply issue is. Typically, as demand for a particular product grows naturally, supply grows alongside demand and the market stays balanced. In the case of marijuana, demand has and will not grow at a steady, natural pace. Canadian demand was constrained up until last year by a federal ban on recreational marijuana use. Now that that ban has been lifted, there is a boom in demand. Suppliers can't keep pace.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Vice Stocks to Spice Up Your Portfolio The situation in Canada is a potential preview of the problems the marijuana industry will face if marijuana is ultimately legalized in the U.S. as well. Marijuana producers are frantically trying to beef up their production, but they are facing an uphill battle. In addition to limited capacity, Canadian marijuana stocks have limited access to U.S. capital. Most banks are unwilling to deal with the headache of investing in companies running operations that are still technically illegal in the U.S. at a federal level.In a nutshell, there are dozens of small-time Canadian and U.S. marijuana companies putting their pedals to the medal to ramp up production. Unfortunately, companies with limited resources can only grow so fast organically. As a result, there has been a flurry of marijuana buyouts and partnerships. That trend will likely continue in the coming years.Given the current supply-constrained environment, the biggest buyers could end up dominating the market in the long-term. In addition, the biggest buyout targets could command a hefty premium given the limited supply. Likely Buyer: Canopy GrowthCanopy Growth (NYSE: CGC) has already been aggressively adding to its capacity. In late April, Canopy announced a $3.4 billion conditional buyout of U.S. marijuana producer Acreage Holdings (OTCMKTS:ACRGF). The deal is contingent upon U.S. federal marijuana legalization. Bank of America analyst Christopher Carey says investors can expect plenty more buyout deals ahead for marijuana stocks like Canopy."We think Canopy showed that there are many options for Canadian marijuana companies to create value, and with Canada supply chain constraints likely to sustain near-term, we see potential that more deals are announced, potentially in the US, in the coming months," Carey says.Canopy has $3 billion in cash on hand but only had to commit $300 million up-front for Acreage given the conditional nature of the deal. Canopy has become the leader in Canadian production. It will likely be aggressive in establishing a similar position in the U.S. market. CGC stock investors can expect Canopy to pursue similarly structured deals with other U.S. producers. If Canopy is aggressive, it can have its pick of the top U.S. producers, leaving competitors to pick up the scraps once marijuana is legalized in the U.S. Potential Seller: HexoIn addition to the best potential marijuana buyer, Hexo (NYSE: HEXO) could be the best buyout target. With a market cap of under $1.7 billion, Hexo is certainly large enough to make a difference without being too big to digest. Carey says Hexo is relatively low-risk as far as Canadian marijuana stocks go. HEXO stock should benefit from its five-year contract as the official supplier of the province of Quebec. It is also expanding its own capacity with smaller deals, including the recent $260 million acquisition of Newstrike Brands.There are two key reasons why Hexo stock stands out as the best potential buyout target. First, Carey says HEXO stock is a rare value among marijuana stocks."We think Hexo is the most attractively valued stock in our coverage group based on our valuation framework of EV/sales (near-term delivery) and DCF (long-term value creation)," Carey says.Carey says Hexo trades at a discounted valuation to its larger-cap peers due to its limited capacity for global expansion. However, this limited global growth trajectory is the second reason HEXO stock makes a great buyout target. If Canopy, Aurora Cannabis (NYSE: ACB) or even a U.S. tobacco company like British American Tobacco (NYSE: BTI) decides to make a big splash with a deal, they have the global presence to get the most value out of Hexo's limited operation. * 7 Energy Stocks to Buy to Light Up Your Portfolio Takeaway For Marijuana StocksThe Canadian sales drop highlights just how much of a mess the marijuana market is in these days. Too many suppliers have too little capacity and limited ability to grow organically. As a result, a wave of consolidation among marijuana stocks is inevitable. The long-term winners of this consolidation will be potential buyers like CGC stock and potential sellers like HEXO stock.As of this writing, Wayne Duggan did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Energy Stocks to Buy to Light Up Your Portfolio * 10 Vice Stocks to Spice Up Your Portfolio * 7 of the Best ETFs to Buy for a Slowing Economy Compare Brokers The post 2 Marijuana Stocks to Buy Despite Declining Canadian Sales appeared first on InvestorPlace.
The FDA in March proposed limiting sales of fruity e-cigarette flavors to age-restricted stores to curb what it has labeled a teen vaping "epidemic." Reynolds says the plan is "overly broad" and the FDA should instead focus on Juul.
The FTSE 100 ended 0.4 percent lower and the more domestically-focused FTSE 250 inched down 0.1 percent. Shell shed 1.4 percent to a month low and BP gave up 2.1 percent, as crude prices weakened after U.S. oil inventories rose more-than-expected with output reaching a new record of 12.3 million barrels per day. As sterling rose to multi-week highs with lingering hopes of progress in cross-party Brexit talks and ahead of Bank of England interest rate meeting on Thursday, exporter companies bore the brunt as much of their revenue is earned in dollars.
The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines UK ad watchdog probes BAT over e-cigarette Instagram posts ...
Altria Down ~6% after Posting Disappointing Q1 EarningsFirst-quarter performance Altria Group (MO) posted its first-quarter earnings on April 25. For the quarter ended on March 31, the company reported adjusted EPS of $0.90, and revenues, net of
Contrary to conventional wisdom, you don't need a hefty trust fund or deep pockets like mutual funds and other institutional players to start investing.
Altria Missed Revenue and Earnings Estimates in Q1(Continued from Prior Part)Stock performance Altria Group (MO) posted lower-than-expected first-quarter results on April 25. The results might have led to a fall in the company’s stock price. In
The world's second-largest tobacco company, in February, forecast "another year of high single figure adjusted constant currency earnings growth" for 2019 and noted a board proposal to increase its dividend by 4 percent. The maker of Lucky Strike and Dunhill cigarettes had reported higher full-year adjusted sales and profit, boosted by cigarette market share gains and higher sales of vaping devices. "While our business is continuing to perform very well we are very conscious that investor sentiment over the last year has been negatively impacted by concerns over possible regulation in the U.S. and competitor dynamics in new categories resulting in a sharp fall in our share price," Burrows said.
What’s Expected for Altria’s First-Quarter EarningsStock performanceAltria Group (MO) is set to report its first-quarter earnings on April 25. As of April 18, Altria stock was trading at $54.37, 13.7% higher than when it announced its
Philip Morris Beat Analysts' ESP and Revenue Expectations in Q1(Continued from Prior Part)Stock performancePhilip Morris International (PM) outperformed analysts’ revenue and EPS expectations in the first quarter. Despite strong first-quarter
Tobacco stocks fell Thursday, after Senate Majority Leader Mitch McConnell (Repub-Ky.) said he would introduce legislation that would raise the age to buy tobacco from 18 to 21. The new age limit would apply to all vaping and tobacco products, although young members of the military would be exempted. The news comes after a long campaign by outgoing Food and Drug Administration Commissioner Scott Gottlieb to crack down on teen vaping. Altria Group Inc. shares fell 2.7%, while Philip Morris International Inc. was down 1.1%. U.S.-listed shares of British American Tobacco fell 1.3%.
The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times Sergio Bucher is to be replaced as ...
Why Investors Are Optimistic about Philip Morris’s Q1 EarningsPM’s performancePhilip Morris International (PM) is scheduled to report its first-quarter earnings results before the market opens on April 18.As of April 11, the company was trading
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Philip Morris' (PM) Q1 performance to gain from high pricing and advancements in RRPs. However, declining cigarette volumes are a worry.
Philip Morris (PM) is benefiting from focus on reduced-risk products, which is reconfirmed by its latest launch of "The Year of Unsmoke."